Delivery Order SPE2DB22D2206-SPE2DB25FJD04
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml with a ceiling value of $2,177.06. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with a ceiling value of $1,692.67. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for completion by August 15, 2025. The award represents a small-value pharmaceutical procurement typical of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $17,136.44. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,272.60 and completion deadline of August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's established role as a critical pharmaceutical supplier to the Department of Defense. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL with a ceiling value of $1,993.27. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside provisions, indicating it was competitively awarded. This...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed-price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 15, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, valued at $3,876.32. This firm fixed-price delivery order, which is not a set-aside contract, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD04Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML with a ceiling value of $1,831.16. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC vehicle provides comprehensive pharmaceutical support globally, enabling delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements, with contract values ranging from minimal transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/29/25 |